Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate GB004 in Adult Subjects With Mild-to-moderate Active Ulcerative Colitis

NCT04556383 is registered in ClinicalTrials.gov with GB004, Inc. as lead sponsor.

NCT NCT04556383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04556383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate GB004 in Adult Subjects With Mild-to-moderate Active Ulcerative Colitis
Lead sponsor
GB004, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
October 19, 2020
Completion date
June 1, 2022
Enrollment
236 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis